Alignment Healthcare, Inc. (NASDAQ:ALHC) Given Consensus Rating of "Moderate Buy" by Brokerages

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven analysts that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $11.88.

Several equities research analysts have issued reports on the company. UBS Group raised their target price on Alignment Healthcare from $9.00 to $12.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 30th. Barclays raised their target price on Alignment Healthcare from $7.00 to $8.00 and gave the company an "underweight" rating in a report on Wednesday, October 30th. Stifel Nicolaus raised their target price on Alignment Healthcare from $14.00 to $16.00 and gave the company a "buy" rating in a report on Tuesday, January 14th. Finally, Stephens restated an "overweight" rating and set a $17.00 target price on shares of Alignment Healthcare in a report on Thursday, January 2nd.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, insider Hakan Kardes sold 35,000 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $12.80, for a total transaction of $448,000.00. Following the transaction, the insider now owns 320,444 shares of the company's stock, valued at $4,101,683.20. The trade was a 9.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Sebastian Burzacchi sold 8,550 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $11.26, for a total value of $96,273.00. Following the transaction, the chief operating officer now directly owns 217,395 shares in the company, valued at approximately $2,447,867.70. This trade represents a 3.78 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 476,002 shares of company stock valued at $6,220,726. Corporate insiders own 6.60% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. R Squared Ltd purchased a new position in shares of Alignment Healthcare in the 4th quarter valued at approximately $55,000. nVerses Capital LLC purchased a new stake in shares of Alignment Healthcare in the third quarter valued at approximately $95,000. RiverPark Advisors LLC purchased a new stake in shares of Alignment Healthcare in the fourth quarter valued at approximately $106,000. Tower Research Capital LLC TRC boosted its stake in shares of Alignment Healthcare by 146.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after buying an additional 6,286 shares in the last quarter. Finally, Ballentine Partners LLC purchased a new stake in shares of Alignment Healthcare in the fourth quarter valued at approximately $121,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Alignment Healthcare Price Performance

Alignment Healthcare stock traded down $1.21 during midday trading on Tuesday, reaching $13.17. The company had a trading volume of 2,613,574 shares, compared to its average volume of 1,797,702. The company has a market capitalization of $2.52 billion, a P/E ratio of -17.10 and a beta of 1.50. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $15.82. The firm's fifty day simple moving average is $13.16 and its 200-day simple moving average is $11.73. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.